Get Premium to unlock powerful stock data
NAS:CTKB (USA)  
Cytek Biosciences Inc logo

Cytek Biosciences Inc

$ 11.03 +0.05 (+0.46%) 04:00 PM EST
P/E:
At Loss
P/B:
3.64
Market Cap:
$ 1.48B
Enterprise V:
$ 1.13B
Volume:
890.19K
Avg Vol (2M):
887.23K
Also Trade In:
Volume:
890.19K
Market Cap $:
1.48B
PE Ratio:
At Loss
Avg Vol (2-Month):
887.23K
Enterprise Value $:
1.13B
PB Ratio:
3.64
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Cytek Biosciences Inc
NAICS : 423450 SIC : 3845
47215 Lakeview Boulevard, Fremont, CA, USA, 94538
Description
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells.
Name Current Vs Industry Vs History
Cash-To-Debt 24.33
Equity-to-Asset 0.84
Debt-to-Equity 0.04
Debt-to-EBITDA 2.13
Interest Coverage 2.9
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 12.56
Distress
Grey
Safe
Beneish M-Score -1.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
Future 3-5Y Total Revenue Growth Rate Industry Rank 26.01

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 66.56
9-Day RSI 61.43
14-Day RSI 58.16
6-1 Month Momentum % -29.18

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.26
Quick Ratio 9.37
Cash Ratio 8.47
Days Inventory 203.85
Days Sales Outstanding 67.73
Days Payable 26.57

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-09-02 Est.)

CTKB's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:CTKB

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 138.742
EPS (TTM) ($) -0.017
Beta 0
Volatility % 0
14-Day RSI 58.16
14-Day ATR ($) 0.637563
20-Day SMA ($) 10.4315
12-1 Month Momentum % 0
52-Week Range ($) 7.38 - 28.7
Shares Outstanding (Mil) 134.31

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Cytek Biosciences Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More